Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 Cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660. (Epub 20210204).
Little AG, Gay EG, Gaspar LE, Stewart AK. National survey of non-small cell lung cancer in the United States: epidemiology, pathology and patterns of care. Lung Cancer. 2007;57(3):253–60. https://doi.org/10.1016/j.lungcan.2007.03.012. (Epub 20070423).
Chang JT, Lee YM, Huang RS. The impact of the cancer genome atlas on lung cancer. Transl Res. 2015;166(6):568–85. https://doi.org/10.1016/j.trsl.2015.08.001. (Epub 20150810).
Article CAS PubMed PubMed Central Google Scholar
Brahmer JR, Tykodi SS, Chow LQ, Hwu WJ, Topalian SL, Hwu P, et al. Safety and activity of anti-Pd-L1 antibody in patients with advanced cancer. N Engl J Med. 2012;366(26):2455–65. https://doi.org/10.1056/NEJMoa1200694. (Epub 20120602).
Article CAS PubMed PubMed Central Google Scholar
Nimmerjahn F, Ravetch JV. Fcgamma receptors as regulators of immune responses. Nat Rev Immunol. 2008;8(1):34–47. https://doi.org/10.1038/nri2206.
Article CAS PubMed Google Scholar
Chan AC, Carter PJ. Therapeutic antibodies for autoimmunity and inflammation. Nat Rev Immunol. 2010;10(5):301–16. https://doi.org/10.1038/nri2761.
Article CAS PubMed Google Scholar
Fanger MW, Shen L, Graziano RF, Guyre PM. Cytotoxicity mediated by human Fc receptors for Igg. Immunol Today. 1989;10(3):92–9. https://doi.org/10.1016/0167-5699(89)90234-x.
Article CAS PubMed Google Scholar
Lyubchenko TA, Wurth GA, Zweifach A. Role of calcium influx in cytotoxic T lymphocyte lytic granule exocytosis during target cell killing. Immunity. 2001;15(5):847–59. https://doi.org/10.1016/s1074-7613(01)00233-3.
Article CAS PubMed Google Scholar
Patel D, Guo X, Ng S, Melchior M, Balderes P, Burtrum D, et al. Igg isotype, glycosylation, and Egfr expression determine the induction of antibody-dependent cellular cytotoxicity in vitro by cetuximab. Hum Antibodies. 2010;19(4):89–99. https://doi.org/10.3233/hab-2010-0232.
Article CAS PubMed Google Scholar
Prang N, Preithner S, Brischwein K, Göster P, Wöppel A, Müller J, et al. Cellular and complement-dependent cytotoxicity of Ep-Cam-specific monoclonal antibody Mt201 against breast cancer cell lines. Br J Cancer. 2005;92(2):342–9. https://doi.org/10.1038/sj.bjc.6602310.
Article CAS PubMed PubMed Central Google Scholar
Coënon L, Villalba M. From Cd16a biology to antibody-dependent cell-mediated cytotoxicity improvement. Front Immunol. 2022;13:913215. https://doi.org/10.3389/fimmu.2022.913215. (Epub 20220603).
Article CAS PubMed PubMed Central Google Scholar
Zahavi D, Weiner L. Monoclonal antibodies in cancer therapy. Antibodies (Basel). 2020. https://doi.org/10.3390/antib9030034. (Epub 20200720).
Wang Z, Jensen MA, Zenklusen JC. A practical guide to the cancer genome atlas (Tcga). Methods Mol Biol. 2016;1418:111–41. https://doi.org/10.1007/978-1-4939-3578-9_6.
Mermel CH, Schumacher SE, Hill B, Meyerson ML, Beroukhim R, Getz G. Gistic2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 2011;12(4):R41. https://doi.org/10.1186/gb-2011-12-4-r41. (Epub 20110428).
Article CAS PubMed PubMed Central Google Scholar
Clough E, Barrett T. The gene expression omnibus database. Methods Mol Biol. 2016;1418:93–110. https://doi.org/10.1007/978-1-4939-3578-9_5.
Article PubMed PubMed Central Google Scholar
Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cbioportal. Sci Signal. 2013;6(269):l1. https://doi.org/10.1126/scisignal.2004088. (Epub 20130402).
Mariathasan S, Turley SJ, Nickles D, Castiglioni A, Yuen K, Wang Y, et al. Tgfβ attenuates tumour response to Pd-L1 blockade by contributing to exclusion of T cells. Nature. 2018;554(7693):544–8. https://doi.org/10.1038/nature25501. (Epub 20180214).
Article CAS PubMed PubMed Central Google Scholar
Sun D, Wang J, Han Y, Dong X, Ge J, Zheng R, et al. Tisch: a comprehensive web resource enabling interactive single-cell transcriptome visualization of tumor microenvironment. Nucleic Acids Res. 2021;49(D1):D1420–30. https://doi.org/10.1093/nar/gkaa1020.
Article CAS PubMed Google Scholar
Zhang L, Guan M, Zhang X, Yu F, Lai F. Machine-learning and combined analysis of single-cell and bulk-Rna sequencing identified a Dc gene signature to predict prognosis and immunotherapy response for patients with lung adenocarcinoma. J Cancer Res Clin Oncol. 2023;149(15):13553–74. https://doi.org/10.1007/s00432-023-05151-w. (Epub 20230728).
Article CAS PubMed PubMed Central Google Scholar
Stelzer G, Rosen N, Plaschkes I, Zimmerman S, Twik M, Fishilevich S, et al. The genecards suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinform. 2016;54:1–3. https://doi.org/10.1002/cpbi.5. (Epub 20160620).
Van de Sande B, Flerin C, Davie K, De Waegeneer M, Hulselmans G, Aibar S, et al. A scalable scenic workflow for single-cell gene regulatory network analysis. Nat Protoc. 2020;15(7):2247–76. https://doi.org/10.1038/s41596-020-0336-2. (Epub 20200619).
Article CAS PubMed Google Scholar
Wilkerson MD, Hayes DN. Consensusclusterplus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26(12):1572–3. https://doi.org/10.1093/bioinformatics/btq170. (Epub 20100428).
Article CAS PubMed PubMed Central Google Scholar
Yu G, Wang LG, Han Y, He QY. Clusterprofiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284–7. https://doi.org/10.1089/omi.2011.0118. (Epub 20120328).
Article CAS PubMed PubMed Central Google Scholar
Hänzelmann S, Castelo R, Guinney J. Gsva: gene set variation analysis for microarray and Rna-Seq data. BMC Bioinform. 2013;14:7. https://doi.org/10.1186/1471-2105-14-7. (Epub 20130116).
Zeng D, Ye Z, Shen R, Yu G, Wu J, Xiong Y, et al. Iobr: multi-omics immuno-oncology biological research to decode tumor microenvironment and signatures. Front Immunol. 2021;12:687975. https://doi.org/10.3389/fimmu.2021.687975. (Epub 20210702).
Article CAS PubMed PubMed Central Google Scholar
Sun D, Guan X, Moran AE, Wu LY, Qian DZ, Schedin P, et al. Identifying phenotype-associated subpopulations by integrating bulk and single-cell sequencing data. Nat Biotechnol. 2022;40(4):527–38. https://doi.org/10.1038/s41587-021-01091-3. (Epub 20211111).
Article CAS PubMed Google Scholar
Fang Z, Tian Y, Sui C, Guo Y, Hu X, Lai Y, et al. Single-cell transcriptomics of proliferative phase endometrium: systems analysis of cell-cell communication network using cellchat. Front Cell Dev Biol. 2022;10:919731. https://doi.org/10.3389/fcell.2022.919731. (Epub 20220722).
Article PubMed PubMed Central Google Scholar
Yang W, Soares J, Greninger P, Edelman EJ, Lightfoot H, Forbes S, et al. Genomics of drug sensitivity in cancer (Gdsc): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 2013;41((Database issue)):955–61. https://doi.org/10.1093/nar/gks1111. (Epub 20121123).
Maeser D, Gruener RF, Huang RS. Oncopredict: An R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform. 2021. https://doi.org/10.1093/bib/bbab260.
Article PubMed PubMed Central Google Scholar
Wu C, Zhang J, Wang K, Fan M, Hu Y. Fam117a is a new prognostic marker of lung adenocarcinoma and predicts sensitivity to Pd0332991. Evid Based Complem Alternat Med. 2022;2022:3945446. https://doi.org/10.1155/2022/3945446. (Epub 20220303).
Shi X, Wu J, Liu Y, Jiang Y, Zhi C, Li J. Ero1l promotes Nsclc development by modulating cell cycle-related molecules. Cell Biol Int. 2020;44(12):2473–84. https://doi.org/10.1002/cbin.11454. (Epub 20200915).
Article CAS PubMed PubMed Central Google Scholar
Nagoya A, Sada R, Kimura H, Yamamoto H, Morishita K, Miyoshi E, et al. Ckap4 is a potential exosomal biomarker and therapeutic target for lung cancer. Transl Lung Cancer Res. 2023;12(3):408–26. https://doi.org/10.21037/tlcr-22-571. (Epub 20230317).
Article CAS PubMed PubMed Central Google Scholar
Meng W, Meng J, Jiang H, Feng X, Wei D, Ding Q (2020) Fkbp4 accelerates malignant progression of non-small-cell lung cancer by activating the Akt/Mtor signaling pathway. Anal Cell Pathol (Amst) 2020: 6021602. Epub 20201204. https://doi.org/10.1155/2020/6021602
Fling SP, Arp B, Pious D. Hla-Dma and -Dmb genes are both required for Mhc Class Ii/peptide complex formation in antigen-presenting cells. Nature. 1994;368(6471):554–8. https://doi.org/10.1038/368554a0.
留言 (0)